# Twirla

NDC: 71671-100
Generic name: levonorgestrel/ethinyl estradiol
Labeler / Manufacturer: Agile Therapeutics, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: PATCH
Routes: TRANSDERMAL
Marketing started: 20200911

FDA application: NDA204017

## Active ingredients

- ETHINYL ESTRADIOL: 2.3 mg/1
- LEVONORGESTREL: 2.6 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71671-100"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71671-100
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bcaf8db0-1750-425d-b008-255b5e7a9cc6